Amalgamated Financial Corp.
For the period ended Dec 31, 2025. Filed Mar 5, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 5, 2026
AMAL$50.53+2.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 3.
| Consolidated Statements of Cash Flows(Dollars in thousands) | |||
|---|---|---|---|
| Year Ended December 31, | |||
| 2025 | 2024 | 2023 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| Net income | $104,447 | $106,434 | $87,978 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 6,222 | 4,703 | 5,509 |
| Amortization of intangible assets | 574 | 730 | 888 |
| Deferred income tax expense | 1,677 | 5,175 | 4,244 |
| Provision for credit losses | 16,323 | 10,284 | 14,670 |
| Stock-based compensation expense | 6,918 | 5,534 | 4,687 |
| Net (income) loss from equity method investments | 1,733 | 831 | (4,932) |
| Net loss on sale of securities available for sale and other assets | 3,431 | 9,698 | 7,392 |
| Net (gain) loss on sale of loans and change in fair value on loans held-for-sale | 2,720 | 8,197 | (32) |
| Net gain on death benefits of bank-owned life insurance | (562) | — | (613) |
| Net gain on repurchase of subordinated debt | — | (1,076) | (1,417) |
| Proceeds from sales of loans held for sale | 29,027 | 22,131 | 17,799 |
| Originations of loans held for sale | (30,132) | (21,702) | (14,558) |
| Increase in cash surrender value of bank-owned life insurance | (2,562) | (2,498) | (2,269) |
| Increase in accrued interest receivable | (3,956) | (5,688) | (14,043) |
| Decrease (increase) in other assets | (856) | (2,440) | 11,740 |
| Increase (decrease) in other liabilities | 778 | (16,248) | 181 |
| Net cash provided by operating activities | 135,782 | 124,065 | 117,224 |
| CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Net increase in loans | (342,040) | (360,157) | (317,211) |
| Proceeds from sales of loans | 73,232 | 36,590 | — |
| Purchase of securities available for sale | (964,986) | (824,549) | (116,453) |
| Purchase of securities held-to-maturity | (157,951) | (92,169) | (264,498) |
| Proceeds from sales of securities available for sale | 364,841 | 394,118 | 285,408 |
| Maturities, principal payments and redemptions of securities available for sale | 477,862 | 310,786 | 167,783 |
| Maturities, principal payments and redemptions of securities held-to-maturity | 190,856 | 204,346 | 108,877 |
| Decrease (increase) in resell agreements | (24,921) | 26,259 | (24,246) |
| Decrease (increase) in equity method investments | (6,472) | 1,908 | (757) |
| Decrease (increase) in FHLBNY stock, net | 10,684 | (11,304) | 25,218 |
| Purchases of premises and equipment, net | (1,379) | (1,775) | (1,477) |
| Proceeds from redemption of bank-owned life insurance | 2,209 | — | 2,949 |
| Proceeds from sale of owned assets | 46 | — | — |
| Net cash used in investing activities | (378,019) | (315,947) | (134,407) |
| CASH FLOWS FROM FINANCING ACTIVITIES | |||
| Net increase in deposits | 768,636 | 168,617 | 416,951 |
| Increase (decrease) in other borrowings, net | (244,946) | 16,325 | (345,619) |
| Repurchase of subordinated debt | — | (5,925) | (6,047) |
| Common stock issued under Equity Program | 1,387 | 789 | 804 |
| Redemption of AREMCO class B shares | — | (152) | — |
| Repurchase of common stock | (32,346) | (1,130) | (8,315) |
| Dividends paid on common stock | (17,203) | (14,234) | (12,333) |
| Payments related to repurchase of common stock for equity awards | (2,823) | (2,229) | (1,228) |
|---|---|---|---|
| Net cash provided by financing activities | 472,705 | 162,061 | 44,213 |
| Increase (decrease) in cash, cash equivalents, and restricted cash | 230,468 | (29,821) | 27,030 |
| Cash, cash equivalents, and restricted cash at beginning of year | 60,749 | 90,570 | 63,540 |
| Cash, cash equivalents, and restricted cash at end of year | $291,217 | $60,749 | $90,570 |
| Supplemental disclosures of cash flow information: | |||
| Interest paid during the year | $124,394 | $128,780 | $85,714 |
| Supplemental non-cash activities: | |||
| Right-of-use assets obtained in exchange for lease liabilities | 2,873 | 560 | — |
| Loans transferred from held-for-sale | 2,472 | — | 4,664 |
| Loans transferred to held-for-sale | 42,540 | 81,589 | 3,581 |
| Cumulative change due to adoption of ASU No. 2016-13 | — | — | 17,825 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.